• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CKPT

CKPT

Checkpoint Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD4.26

+0.00 (+0.00%)

Company Profile

CEO

James F. Oliviero III,

IPO Date

2016-12-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$4.24

Prev. Close

$4.26

Day Low

$4.24

Day High

$4.26

52W Low

$1.80

52W High

$4.50

Market Cap

$0.37B

Volume

8.63M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

23.5%

Avg Negative

3.2%

Avg Neutral

73.3%

News Feed

Checkpoint Therapeutics Reports Second Quarter 2021 Financial Results

GlobeNewsWire·8/5/2021·↑ positive

Checkpoint Therapeutics: Amassing A Position Ahead Of Cosibelimab Data

Seeking Alpha·7/13/2021·↑ positive

Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference

GlobeNewsWire·7/8/2021
·
↑ positive

Why Checkpoint Therapeutics Skyrocketed Today

The Motley Fool·6/9/2021·↓ negative

CKPT Stock Price: Over 30% Increase Pre-Market Explanation

Pulse2·6/9/2021·↑ positive

Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights

GlobeNewsWire·3/9/2021·↑ positive

Checkpoint Therapeutics Announces Formation of Scientific Advisory Board

GlobeNewsWire·3/1/2021·↓ negative

CKPT Stock Price: $16 Target By Cantor Fitzgerald

Pulse2·1/22/2021·↓ negative

Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences

GlobeNewsWire·1/6/2021·↑ positive

Is Checkpoint Therapeutics, Inc. (CKPT) A Good Stock To Buy?

Insider Monkey·11/27/2020·↑ positive